Silva Pharmaceuticals Limited: Company Information & IPO Result

DOWNLOAD LOTTERY RESULT HERE: PUBLISHED

Update: Silva Pharmaceuticals Limited subscription will start from 29 July’18 to 5 August’18

The Bangladesh Securities Exchange Commission (BSEC) approved IPO Silva Pharmaceuticals Limited on Monday, 11 June 2018 at their 647 nos Board Meeting. Presided over by BSEC Chairman Prof. Dr. M Khairul Hossain to issue 3.00 crore ordinary shares worth Tk 10 each. Company Information, IPO Application Form, Prospectus & Result is given below:

COMPANY INFORMATION:

Company Name: Silva Pharmaceuticals Limited. (Hereinafter referred to as “SPL”)
Incorporation: The Company was incorporated on 24 April 2001 as a private limited Company and was subsequently converted into a public limited company on 24 April 2014.
Commercial Operation: Silva Pharmaceuticals Limited was started commercial operation on 1 July 2003.
Authorized Capital: Tk. 1,500,000,000 divided into 150,000,000 ordinary shares of Tk. 10.00 each
Paid Up Capital (Before IPO): Tk. 1,000,000,000 divided into 100,000,000 ordinary shares of Tk. 10.00 each
Paid Up Capital (After IPO): Tk. 1,300,000,000 divided into 130,000,000 ordinary shares of Tk. 10.00 each

Management Body: 1) Mrs. Silvana Mirza, Chairman
2) Dr. Saira Khan, Managing Director & Director
3) Mrs. Samina Mirza, Director
4) Mrs. Farhana Mirza, Director
5) Md. Nazrul Islam Khan, Nominated by Investment Corporation of Bangladesh (ICB)
6) Mr. Monsur Rahman, Nominated by Adarsha Fisheries & Poultry Farm Ltd.
7) Md. Musfiqur Rahman FCA, Independent Director
8) Tanha Zarrin Ahmed , Independent Director

ABOUT THE ISSUER:

Silva Pharmaceuticals Limited has engaged in manufacturing and marketing of pharmaceuticals finished products in the categories of Antibiotics, Analgesics, Anti diabetics, Narcotics, Anti pyretic, Anti-inflammatory Drugs, Anti ulcerants, Antiemetic, Gastroprokinetic, Anti histamine, Anti spasmodic expectorants, Vitamins & Minerals medicines which is selling mainly in local market

PRODUCTS:

The Company has following products: Details Products List

NAME OF SUBSIDIARIES:

There is no subsidiaries company of Silva Pharmaceuticals Limited.

ADDRESS:

Registered & Corporate Office :

House #65, Road # 8/A (New), Dhanmondi, Dhaka-1209.

Phone: +88-02-8129915, +88-02-9146009
Fax: +88-02-9146013
Email: [email protected]

Web Address: www.silvapharma.com

Factory:

1. Silva Pharmaceuticals Limited, Joykrishnapur, Main Road, Maijdee Court, Noakhali – Rented factory building &

2. Binodpur (former Gopai Ram Sankarpur), Maijdee Court, Noakhali -Owned factory building.

MAJOR FINANCIAL INFORMATION AS FOLLOWS:

Figure in Tk.’000

Particulars	30-06-17 (12 Months)	30-06-16 (13 Months)	31-05-15	31-05-14	31-05-13
	Restated
Revenue	602,492	628,766	503,877	493,935	395,148
Gross Profit	236,716	249,255	189,624	203,564	185,902
Net Profit before tax	123,763	114,961	79,935	78,914	71,794
Net Profit after tax	80,279	74,725	51,958	49,321	44,871
Total Assets	1,941,163	1,638,899	1,234,007	1,114,742	10,57,172
Share Capital	1,000,000	500,000	120,000	120,000	120,000
Retained Earnings	647,797	585,378	510,654	475,793	461,604
No. of Shares	100,000	50,000	12,000	12,000	12,000
Face Value	10.00	10.00	10.00	10.00	10.00
NAV per Shares	16.48	21.71	52.55	49.65	48.47
Earnings per Share	1.03	1.24	1.06	1.00	0.91

SILVA PHARMACEUTICALS LIMITED EPS & NAV:

As per the financial statement for the year ended on June 30, 2017, the company’s net asset value (NAV) without revaluation stood at Tk 16.48 per share and weighted average of EPS was Tk 1.03

ISSUE MANAGER:

Prime Finance Capital Management, Imperial Capital Limited and SBL Capital Management Limited are jointly working as the manager of the issue.

WHY PUBLIC OFFERING:

Bangladesh Securities Exchange Commission (BSEC) approved IPO of above Co. on 11 June 2018. The companies will raise a fund worth Tk. 300.00 million.

Proceeds from Initial Public Offering (IPO) will be used for acquisition of Machinery & Equipment,

Construction and other civil works , loan pay off and for IPO Expenses

NOS. OF SHARE OFFER: 3,00,00,000
VALUE OF IPO: Tk. 300,000,000/=
FACE VALUE: Tk. 10/=
PREMIUM VALUE: Nil
MARKET LOT: 500
MINIMUM LOT VALUE: Tk.5000/=
SHARE ALLOTMENT: 32% for General Public=19,200 lot and 8% for Affected Investors=4,800 lot, 40% for Eligible Investor (EI) =24,000 lot, 10% for NRB = 6,000 lot and 10% for Mutual Fund =6,000 lot.

** The Company will collect IPO money through BSEC new rules and the new rule is “BROKER HOUSE SHOULD COLLECT IPO MONEY ONLY”.